Bullish
$SRRA About the ASH 2019 Poster: Title: Dynamic and Time-To-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor–Naïve Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib Session Name: 634. Myeloproliferative Syndromes: Clinical: Poster I Date: Saturday, December 7, 2019 Presentation Time: 5:30 PM - 7:30 PM Location: Orange County Convention Center, Hall B
  • 5
  • 1